CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing demand for nutraceutical products
4.1.2. Increased healthcare spending and evolving eating habits
4.1.3. Increasing use of bioactive ingredients in the production of nutraceuticals
4.1.4. New food structure and compositions are being designed through the use of excipients
4.1.5. Advancements in nanotechnology imparting new functions to excipients
4.2. Market Restraints & Challenges
4.2.1. Difficulties in product formulation
4.2.2. Declining R&D investments
4.3. Market Opportunities
4.3.1. Multi-functionality of excipients
4.3.2. Rising need to stabilize the physicochemical properties of nutraceuticals and dietary supplements during production
CHAPTER 5 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET – BY FUNCTIONALITY
5.1. Binders
5.2. Fillers & Diluents
5.3. Disintegrants
5.4. Coating Agents
5.5. Flavoring Agents
5.6. Lubricants
5.7. Others
CHAPTER 6 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET – BY FORM
6.1. Dry
6.2. Liquid
CHAPTER 7 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET – BY TYPE
7.1. Artificial
7.2. Natural/Organic
CHAPTER 8 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET – BY END USER
8.1. Probiotics
8.2. Prebiotics
8.3. Proteins & Amino Acids
8.4. Vitamins
8.5. Minerals
8.6. Omega-3 Fatty Acids
8.7. Others
CHAPTER 9 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. Asia Pacific
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET - COMPANY PROFILES
10.1. Ingredion, Inc.
10.2. Innophos Holdings, Inc.
10.3. JRS Pharma
10.4. Sensient Colors LLC
10.5. Hilmar Ingredients
10.6. Kerry Group Plc
10.7. Cargill, Incorporated
10.8. Roquette Freres SA
10.9. E. I. Du Pont De Nemours and Company
10.10. Meggle Group Wasserburg
10.11. ABF Ingredients
10.12. IMCD, N.V
10.13. Avantor Performance Materials, LLC
10.14. Ashland Inc.
10.15. Huntsman Corporation
CHAPTER 11 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET - COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12 MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13 APPENDIX
13.1. List of Tables
13.2. List of Figures
